Clinical Roundup Genetic “Trojan horse” selectively kills cancer cells linked to Kaposi’s sarcoma, UC Davis study shows October 03, 2025Vol.51 No.36
Clinical Roundup Wistar scientists identify novel therapeutic target for ovarian cancer October 03, 2025Vol.51 No.36
Clinical Roundup Study assesses cancers in children exposed to medical imaging September 26, 2025Vol.51 No.35
Clinical Roundup Tecvayli + Darzalex Faspro achieves 100% MRD negativity in newly diagnosed MM, phase II study shows September 26, 2025Vol.51 No.35
Clinical Roundup Mammograms may benefit women well into their 80s, UCLA study finds September 26, 2025Vol.51 No.35
Clinical Roundup Korean researchers find CRC patients over 70 years don’t stand to benefit from chemo September 26, 2025Vol.51 No.35
Clinical Roundup Wistar scientists identify novel therapeutic target for ovarian cancer September 26, 2025Vol.51 No.35
Clinical Roundup ALOX15 loss, common in CRC, impairs the cancer-preventative effects of fish oil, mouse study shows September 26, 2025Vol.51 No.35
Clinical Roundup Libtayo + chemo shows significant improvement in OS for advanced NSCLC, phase III EMPOWER-Lung 3 trial shows September 19, 2025Vol.51 No.34
Clinical Roundup Rezatapopt monotherapy shows confirmed responses of eight solid tumor types in PYNNACLE phase II clinical trial September 19, 2025Vol.51 No.34
